du Bois Score for Idiopathic Pulmonary Fibrosis (IPF) Mortality
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
حداقل ۱۰ — حداکثر ۱۵۰ • واحد: % predicted
حداقل -۵۰ — حداکثر ۵۰ • واحد: % predicted change
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–4
- Intermediate Risk5–8
- High Risk9–15
The du Bois Score for Idiopathic Pulmonary Fibrosis (IPF) Mortality calculates stratifying pneumonia severity, respiratory failure progression, and inpatient admission requirements. Key inputs include age. Scores guide determining appropriate admission level (floor versus ICU), tailoring antimicrobial therapy, and ventilatory support. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Determines 1-year mortality risk in IPF patients using PFT and clinical indicators. Developed from two clinical trials (n=1,099) to identify independent predictors of 1-year mortality in idiopathic pulmonary fibrosis.
Clinical Indication
The du Bois Score for Idiopathic Pulmonary Fibrosis (IPF) Mortality is indicated for bedside clinical practice to support Determines 1-year mortality risk in IPF patients using PFT and clinical indicators. Developed from two clinical trials (n=1,099) to identify independent predictors of 1-year mortality in idiopathic pulmonary fibrosis.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.
Limitations & Contraindications
Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.
Clinical Pearls & Action Plan
Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management.
du Bois Score = Age points + Respiratory hospitalization points + FVC % predicted points + FVC change points. Age: 51-60 years (1 pt), 61-70 years (2 pts), >70 years (3 pts). Recent respiratory hospitalization: Yes (2 pts). FVC % predicted: 50-65% (1 pt), <50% (2 pts). FVC decline >10% in 24 weeks: Yes (3 pts).
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient age in years(years) |
| respiratory_hospitalization | string | Yes | History of respiratory hospitalization within the past 6 months |
| fvc_percent_predicted | float | Yes | Forced vital capacity (FVC) as percentage of predicted value(% predicted) |
| change_fvc_24_weeks | float | Yes | Change in FVC over 24 weeks (absolute change in % predicted)(% predicted change) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–4 | Low Risk | Low 1-year mortality risk |
| 5–8 | Intermediate Risk | Intermediate 1-year mortality risk |
| 9–15 | High Risk | High 1-year mortality risk |
Evidence-Based References (EBM)
- du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;184(4):459-66. doi: 10.1164/rccm.201011-1790OC.DOI: 10.1164/rccm.201011-1790OC
- Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156(10):684-91. doi: 10.7326/0003-4819-156-10-201205150-00004.DOI: 10.7326/0003-4819-156-10-201205150-00004
- Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824. doi: 10.1164/rccm.2009-040GL.DOI: 10.1164/rccm.2009-040GL